- Country: Brazil
- Summary: Levodopa 250Mg+Carbidop 25Mg Comp, Amoxicillin 500Mg Caps, Voriconazole 200 Mg Compressed, Formoterol, 12Mcg Caps and Nifedipine 20Mg Caps Retard
- BRT Ref No: 125393578
- Deadline: 10 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 91164/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Subject: Electronic Auction - Levodopa 250mg+Carbidop 25mg comp, amoxicillin 500mg caps, voriconazol 200 mg tablet, formoterol, 12mcg caps and nifedipine 20mg caps retard
at 08:00
Concentration 200 mg
Additional With inhaler bottle
Additional Characteristics 1 Prolonged Release
39636 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLevodopa 250Mg+Carbidop 25Mg Comp, Amoxicillin 500Mg Caps, Voriconazole 200 Mg Compressed, Formoterol, 12Mcg Caps and Nifedipine 20Mg Caps Retard - Brazil Tender
The SAO PAULO STATE GOVERNMENT, a Government sector organization in Brazil, has announced a new tender for Levodopa 250Mg+Carbidop 25Mg Comp, Amoxicillin 500Mg Caps, Voriconazole 200 Mg Compressed, Formoterol, 12Mcg Caps and Nifedipine 20Mg Caps Retard. This tender is published on BrazilTenders under BRT Ref No: 125393578 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
